Skip to main content

Market Overview

32 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Cidara Therapeutics, Inc. (NASDAQ: CDTX) stock increased by 68.5% to $2.83 during Tuesday's pre-market session. The most recent rating by Oppenheimer, on June 06, is at Outperform, with a price target of $6.00.
  • Ardelyx, Inc. (NASDAQ: ARDX) stock rose 22.4% to $4.16. The market cap stands at $255.5 million.
  • Medicines Co, Inc. (NASDAQ: MDCO) stock moved upwards by 15.0% to $48.25. The market cap seems to be at $2.6 billion. The most recent rating by Citigroup, on September 03, is at Buy, with a price target of $55.00.
  • Viveve Medical, Inc. (NASDAQ: VIVE) shares increased by 11.1% to $0.12. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • BioLine Rx, Inc. (NASDAQ: BLRX) shares increased by 10.5% to $3.15.
  • Atossa Genetics, Inc. (NASDAQ: ATOS) stock increased by 8.0% to $2.15. The market value of their outstanding shares is at $5.8 million.
  • Co-Diagnostics, Inc. (NASDAQ: CODX) stock surged 7.5% to $1.15. The market value of their outstanding shares is at $35.7 million.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) shares increased by 3.7% to $0.26.
  • InMode, Inc. (NASDAQ: INMD) stock rose 3.5% to $20.60.
  • Moderna, Inc. (NASDAQ: MRNA) stock rose 3.1% to $16.22.
  • Amarin Corp, Inc. (NASDAQ: AMRN) shares increased by 3.1% to $15.45. The market cap stands at $6.7 billion.
  • Sanofi, Inc. (NASDAQ: SNY) stock rose 3.0% to $44.24. The most recent rating by Bernstein, on September 03, is at Outperform, with a price target of $52.00.
  • Genmab, Inc. (NASDAQ: GMAB) stock rose 2.4% to $20.87. According to the most recent rating by Morgan Stanley, on August 12, the current rating is at Overweight.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) stock surged 1.9% to $1.56. The market value of their outstanding shares is at $30.3 million.
  • Heat Biologics, Inc. (NASDAQ: HTBX) shares moved upwards by 1.9% to $0.52. The market cap stands at $31.8 million. The most recent rating by Brookline Capital, on July 30, is at Buy, with a price target of $8.00.
  • SELLAS Life Sciences, Inc. (NASDAQ: SLS) stock surged 1.0% to $0.14. The market value of their outstanding shares is at $27.0 million.

 

Losers

  • Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares decreased by 27.1% to $8.52 during Tuesday's pre-market session.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) shares plummeted 7.5% to $1.23. The market value of their outstanding shares is at $209.3 million. The most recent rating by Alliance Global Partners, on August 01, is at Neutral, with a price target of $0.40.
  • Akari Therapeutics, Inc. (NASDAQ: AKTX) stock decreased by 7.2% to $1.93. The market cap stands at $28.6 million.
  • Genfit, Inc. (NASDAQ: GNFT) shares decreased by 6.7% to $16.15. The market value of their outstanding shares is at $638.7 million.
  • Mallinckrodt, Inc. (NYSE: MNK) shares decreased by 4.1% to $2.48. The most recent rating by Barclays, on August 28, is at Equal-Weight, with a price target of $5.00.
  • Cancer Genetics, Inc. (NASDAQ: CGIX) shares fell 3.5% to $0.10. The market value of their outstanding shares is at $37.0 million.
  • Lannett, Inc. (NYSE: LCI) shares decreased by 3.1% to $10.00. The market cap stands at $516.9 million. The most recent rating by SunTrust Robinson Humphrey, on August 29, is at Hold, with a price target of $10.00.
  • InflaRx, Inc. (NASDAQ: IFRX) shares decreased by 2.8% to $2.76. The most recent rating by Baird, on June 06, is at Neutral, with a price target of $6.00.
  • AAC Holdings, Inc. (NYSE: AAC) shares decreased by 2.4% to $0.59. The market cap stands at $18.9 million. According to the most recent rating by Raymond James, on August 13, the current rating is at Market Perform.
  • Grifols, Inc. (NASDAQ: GRFS) shares plummeted 2.2% to $20.83. The market cap stands at $14.1 billion. The most recent rating by JP Morgan, on June 27, is at Overweight, with a price target of $22.50.
  • Tilray, Inc. (NASDAQ: TLRY) shares fell 1.6% to $25.27. According to the most recent rating by Ladenburg Thalmann, on July 17, the current rating is at Neutral.
  • Fresenius Medical Care, Inc. (NYSE: FMS) stock declined 1.5% to $33.10. The market cap stands at $21.8 billion. According to the most recent rating by BTIG, on August 01, the current rating is at Neutral.
  • OpGen, Inc. (NASDAQ: OPGN) shares fell 1.4% to $7.10. The market value of their outstanding shares is at $12.3 million.
  • Cronos Group, Inc. (NASDAQ: CRON) stock plummeted 1.3% to $10.88. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.
  • Dr Reddy's Laboratories, Inc. (NYSE: RDY) stock fell 1.1% to $35.41. The market cap seems to be at $9.4 billion. The most recent rating by Barclays, on June 11, is at Equal-Weight, with a price target of $39.00.
  • Alcon, Inc. (NYSE: ALC) shares fell 1.0% to $60.37. The market cap seems to be at $28.1 billion. The most recent rating by Credit Suisse, on August 26, is at Outperform, with a price target of $73.00.
 

Related Articles (AAC + AKTX)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com